1. Efficacy and safety of nivolumab in bone metastases from renal cell carcinoma: Results of the GETUG-AFU26-NIVOREN multicentre phase II study. (March 2023) Authors: Velev, Maud; Dalban, Cécile; Chevreau, Christine; Gravis, Gwenaelle; Negrier, Sylvie; Laguerre, Brigitte; Gross-Goupil, Marine; Ladoire, Sylvain; Borchiellini, Delphine; Geoffrois, Lionnel; Joly, Florence; Priou, Frank; Barthelemy, Philippe; Laramas, Mathieu; Narciso, Berangère; Thiery-Vuillemin,... Journal: European journal of cancer Issue: Volume 182(2023) Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗